University College London Featured PhD Programmes
University of Oxford Featured PhD Programmes
University College London Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
Life Science Zurich Graduate School Featured PhD Programmes
"screening"×
10 miles

Pharmaceutical / Medicinal Chemistry (screening) PhD Projects, Programs & Scholarships

We have 14 Pharmaceutical / Medicinal Chemistry (screening) PhD Projects, Programs & Scholarships

  • "screening" ×
  • Pharmaceutical / Medicinal Chemistry×
  • clear all
Order by 
Showing 1 to 10 of 14
  MRC DiMeN Doctoral Training Partnership: Software, Synthesis and Screening: cheminformatic led invention, design and synthesis of novel compounds for the treatment of septic shock
  Prof JPA Harrity, Dr G Richards, Dr A Hogben, Dr A Pannifer
Application Deadline: 6 January 2020

Funding Type

PhD Type

Industrial and academic medicinal chemists take advantage of modern cheminformatic and biology technologies to inform and guide their science.
  Next-generation protein engineering: integration of ab-initio modelling, high-throughput screening and structural fingerprinting by mass spectrometry.
  Research Group: BBSRC White Rose DTP
  Dr E Paci, Dr D Tomlinson, Prof F. Sobott
Application Deadline: 6 January 2020

Funding Type

PhD Type

Recombinant proteins are playing an ever-increasing role as therapeutics and reagents in biotechnology. Rationally engineering proteins requires understanding of the principles behind protein interactions.
  Designing better wound dressings that mimic the body
  Dr A Hook, Dr C Merry
Applications accepted all year round

Funding Type

PhD Type

This project aims to design better wound dressings that can actively promote healing within chronic wounds.
  Chemo-enzymatic Synthesis and Potential Applications of Novel Heterocyclic Alkaloids
  Dr H Deng, Dr L Trembleau
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is rising to dangerously high levels in all parts of the world. In Europe alone, drug-resistant bacteria are estimated to cause 25,000 deaths annually and cost more than US$1.5 billion every year in healthcare expenses and productivity losses.
  Advanced functional MRI for the characterisation of paediatric glioma and its response to therapy
  Dr S Robinson, Dr C Jones
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Discovery of Antibiotics from Cyanobacteria (TRUMANJ20DTP)
  Dr A Truman
Application Deadline: 25 November 2019

Funding Type

PhD Type

Bacteria have the capacity to produce natural products with exquisite bioactivities, which makes these compounds excellent candidates as medicines and agrochemicals.
  MRC DiMeN Doctoral Training Partnership: Drug discovery to control C. difficile infections by targeting sporulation
  Dr P Salgado, Dr J Hubbard
Application Deadline: 6 January 2020

Funding Type

PhD Type

Interested in a PhD studying antibiotic resistant bacteria and explore new ways to treat drug-resistant infections? In this PhD, you will use a range of biochemistry, biophysical and structural techniques, together with molecular biology, genetics, and microbiology approached to develop new therapeutics targeting C.
  (BBRSC DTP CASE) Controlling interfacial adsorption of bispecific therapeutics using multivalent ions
  Dr R Curtis, Dr A Pluen, Dr C F Blanford
Application Deadline: 31 January 2020

Funding Type

PhD Type

ImmTAC molecules are a promising new class of bispecific therapeutics produced by Immunocore for applications in oncology and as new treatments for infectious diseases.
  (BBSRC DTP CASE) Discovery and Engineering of Expanded Halogenases for Late Stage Enzymatic Functionalisation
  Prof J Micklefield, Prof P Barran
Application Deadline: 31 January 2020

Funding Type

PhD Type

The project aims to discover and engineer novel enzymes (biocatalysts) that can affect regioselective halogenation of complex molecules enabling more efficient and environmentally sustainable production of pharmaceuticals which are urgently required to combat disease.
  (BBSRC DTP CASE) Exploitation of P450 BM3 variants for production of valuable drug metabolites
  Prof A Munro, Prof D Leys
Application Deadline: 31 January 2020

Funding Type

PhD Type

The US Food and Drug Administration (FDA) have recommended that human drug metabolites (as well as their parent drugs) should be subject to testing for safety/toxicity.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.